- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
NovX21 Closes $3 million Private Placement, Commences Trading on TSX Venture Exchange
NovX21 Inc. (TSXV:NOV), previously Pro-Or Inc., has closed a previously announced $3 million private placement at a price of $0.10 per share. The TSX Venture Exchange has also accepted the Company’s change of business and name change to NovX21 Inc., commencing trade on January 21, 2014.
As quoted in the press release:
Common shares of the Corporation (“Common Shares”) were offered to accredited investors. Each Common Share is accompanied by one common share purchase warrant, entitling the holder to acquire one Common Share at an exercise price of $0.20 per Common Share for a period of 36 months from the date of issuance. The warrants are subject to an acceleration clause by which the warrant period of the warrants can be reduced, at the Corporation’s discretion, if the closing price of the Common Shares on the Exchange is equal to or above $0.30 on 20 consecutive trading days, in which case the exercise period of the warrants will be reduced to 30 days following formal written notification by the Corporation to that effect.
NovX21 President and CEO, Sylvain Boulanger, said:
We are very pleased to have successfully reached our goal of securing this equity financing that will allow us to build our first 200-tonne commercial recovery plant. This will propel the Corporation to an upward level of its development and will facilitate our discussions with debt investors, potential offtake agreements and commercial bank lenders.
Click here to read the NovX21 Inc. (TSXV:NOV) press release
Click here to see the NovX21 Inc. (TSXV:NOV) profile.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.